Osborne Vicki, Serdarevic Mirsada, Crooke Hannah, Striley Catherine, Cottler Linda B
Department of Epidemiology, University of Florida, Gainesville, United States.
Department of Epidemiology, University of Florida, Gainesville, United States.
Addict Behav. 2017 Sep;72:114-119. doi: 10.1016/j.addbeh.2017.03.024. Epub 2017 Mar 31.
Non-medical use (NMU) of prescription opioids in youth is of concern since they may continue this pattern into adulthood and become addicted or divert medications to others. Research into risk factors for NMU can help target interventions to prevent non-medical use of opioids in youth.
The National Monitoring of Adolescent Prescription Stimulants Study (N-MAPSS) was conducted from 2008 to 2011. Participants 10-18years of age were recruited from entertainment venues in urban, rural and suburban areas of 10 US cities. Participants completed a survey including questions on their use of prescription opioids. NMU was defined as a non-labeled route of administration or using someone else's prescription. Information on age, gender, alcohol, marijuana and tobacco use was also collected. Summary descriptive, chi-square statistics and logistic regression were conducted using SAS 9.4.
Of the 10,965 youth who provided information about past 30day prescription opioid use, prevalence of reported opioid use was 4.8% with 3.2% reported as NMU (n=345) and 1.6% as medical use (MU) only (n=180). More males than females (55.7% vs. 44.4%) reported opioid NMU (p<0.0001). Logistic regression revealed that among males (comparing NMU to MU only), current smokers were 4.4 times more likely to report opioid NMU than non-smokers (95% CI: 1.8, 10.7). Among females (comparing NMU to MU only), current smokers and alcohol users were more likely to report opioid NMU than those who had never smoked or used alcohol (OR=3.2, 95% CI: 1.4, 7.0 and OR=4.1, 95% CI: 1.7, 10.4, respectively).
These results suggest that further research on gender differences in opioid NMU is needed; interventions for opioid NMU may need to be gender specific to obtain the best results.
青少年非医疗用途(NMU)使用处方阿片类药物令人担忧,因为他们可能会将这种模式延续至成年,进而成瘾或把药物转给他人。对非医疗用途的风险因素进行研究有助于针对性地采取干预措施,以预防青少年非医疗用途使用阿片类药物。
2008年至2011年开展了全国青少年处方兴奋剂监测研究(N-MAPSS)。从美国10个城市的城市、农村和郊区的娱乐场所招募了10至18岁的参与者。参与者完成了一项调查,其中包括有关他们使用处方阿片类药物的问题。非医疗用途被定义为非标签给药途径或使用他人的处方。还收集了有关年龄、性别、酒精、大麻和烟草使用的信息。使用SAS 9.4进行汇总描述性统计、卡方统计和逻辑回归分析。
在10965名提供过去30天处方阿片类药物使用信息的青少年中,报告的阿片类药物使用率为4.8%,其中3.2%报告为非医疗用途(n = 345),1.6%仅为医疗用途(MU)(n = 180)。报告阿片类药物非医疗用途的男性多于女性(55.7%对44.4%)(p < 0.0001)。逻辑回归分析显示,在男性中(将非医疗用途与仅医疗用途进行比较),当前吸烟者报告阿片类药物非医疗用途的可能性是非吸烟者的4.4倍(95%置信区间:1.8,10.7)。在女性中(将非医疗用途与仅医疗用途进行比较),当前吸烟者和饮酒者报告阿片类药物非医疗用途的可能性高于从未吸烟或饮酒者(比值比分别为3.2,95%置信区间:1.4,7.0和4.1,95%置信区间:1.7,10.4)。
这些结果表明,需要进一步研究阿片类药物非医疗用途中的性别差异;针对阿片类药物非医疗用途的干预措施可能需要针对不同性别,以取得最佳效果。